Twist Bioscience Corporation (Nasdaq: TWST)

https://www.twistbioscience.com

Twitter: @TwistBioscience

LinkedIn: https://linkedin.com/company/twist-bioscience

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. *

	Start	2013-01-01 established
	Group	Twist Bioscience (Group)
	Industry	oligo synthesis
	Industry 2	synthetic biotechnology
	Person	LeProust, Emily M. (Twist Bioscience 2013– CEO + Co-Founder before Agilent Director Genomics Application Development)

	Region	South San Francisco, CA
	Country	United States (USA)
	Street	681 Gateway Blvd.
	City	94080 South San Francisco, CA
		Address record changed: 2021-07-05

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Twist Bioscience Corporation. (6/30/21). "Press Release: Twist Bioscience Acquires NGS Library Preparation Maker iGenomX". South San Francisco, CA.

		Record changed: 2021-07-05